Skip to main content
. 2018 Sep 1;11(9):4339–4345.

Table 2.

Prognostic factors for OS and DFS by multivariate analysis

Clinical data HR (95% CI) P value
Overall survival (OS)
    Node stage (N+ vs. N0) 3.17 (1.33-4.90) 0.023
    TNM stage (III/IV vs. I/II) 4.36 (1.56-7.23) 0.008
    Tissue miR-31 (high vs. low) 3.31 (1.42-5.36) 0.015
Disease-free survival (DFS)
    Node stage (N+ vs. N0) 3.52 (1.42-5.69) 0.017
    TNM stage (III/IV vs. I/II) 4.57 (1.71-7.54) 0.001
    Tissue miR-31 (high vs. low) 3.86 (1.53-6.05) 0.009